KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

BioNTech SE (BNTX) EPS (Basic) (2018 - 2025)

BioNTech SE's EPS (Basic) history spans 8 years, with the latest figure at -$1.18 for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 100.0% to -$1.18 in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.65, a 100.0% decrease, with the full-year FY2025 number at -$4.39, down 48.19% from a year prior.
  • EPS (Basic) hit -$1.18 in Q4 2025 for BioNTech SE, down from -$0.12 in the prior quarter.
  • Over the last five years, EPS (Basic) for BNTX hit a ceiling of $240277.8 in Q4 2024 and a floor of -$3.25 in Q2 2024.
  • Historically, EPS (Basic) has averaged $38277.1 across 5 years, with a median of -$0.06 in 2021.
  • Biggest five-year swings in EPS (Basic): soared 128804137.05% in 2022 and later tumbled 324.26% in 2024.
  • Tracing BNTX's EPS (Basic) over 5 years: stood at $0.0 in 2021, then soared by 128804137.05% to $16.71 in 2022, then plummeted by 88.61% to $1.9 in 2023, then skyrocketed by 12625109.29% to $240277.8 in 2024, then plummeted by 100.0% to -$1.18 in 2025.
  • Business Quant data shows EPS (Basic) for BNTX at -$1.18 in Q4 2025, -$0.12 in Q3 2025, and -$1.68 in Q2 2025.